A detailed history of Fortis Group Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 20 shares of TEVA stock, worth $448. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$448
Previous $325,000 10.77%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$10.67 - $14.43 $213 - $288
-20 Reduced 50.0%
20 $282,000
Q4 2023

Mar 04, 2024

BUY
$8.12 - $10.63 $162 - $212
20 Added 100.0%
40 $418,000
Q3 2023

Dec 01, 2023

BUY
$7.48 - $10.7 $149 - $214
20 New
20 $204,000
Q1 2023

May 26, 2023

SELL
$8.36 - $11.37 $167 - $227
-20 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$8.57 - $12.69 $171 - $253
20 New
20 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.